PLXS.NASDAQPlexus CORP

Form 4: Plexus Director Karen Rapp Sells Shares Under Pre-Arranged Trading Plan

Sentiment:

Insider Transaction Report


Plexus Corp. Director Karen Marie Rapp reported the sale of 500 shares of common stock at $130.77 per share on May 30, 2025, executed under a Rule 10b5-1 trading plan.

Summary

  • Karen Marie Rapp, a Director of Plexus Corp. (PLXS), reported a transaction involving the company's common stock.
  • On May 30, 2025, Ms. Rapp disposed of 500 shares of Plexus common stock.
  • The shares were sold at a price of $130.77 per share.
  • Following this transaction, Karen Rapp beneficially owns 9,365 shares of Plexus common stock directly.
  • The sale was conducted pursuant to a Rule 10b5-1 plan, which was adopted on February 28, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The sale of shares by a director, while a reduction in insider ownership, was conducted under a pre-arranged 10b5-1 plan, which is a common and transparent practice for managing personal finances and avoiding accusations of insider trading. The volume of shares sold (500) is relatively small compared to the remaining holdings (9,365), suggesting it's likely a routine financial management decision rather than a reflection of negative sentiment about the company's prospects.

Positives

  • The transaction was executed under a Rule 10b5-1 plan, adopted on February 28, 2024, which indicates a pre-scheduled sale designed to comply with insider trading laws and enhance transparency.

Negatives

  • The transaction represents a reduction in direct insider ownership, as a director sold 500 shares of common stock.

Future Outlook

This Form 4 filing reports a past insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide information relevant to broader industry trends or competitive analysis.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Insider Trading Policy AdherenceThe transaction was conducted pursuant to a Rule 10b5-1 plan adopted on February 28, 2024, demonstrating adherence to corporate governance best practices for insider trading.05/30/2025This practice enhances transparency and mitigates concerns about potential insider trading, aligning the company with regulatory expectations for executive stock transactions.

Related Party Transactions

  • The transaction involves a sale of common stock by Karen Marie Rapp, a Director of Plexus Corp., making it a related party transaction as defined by SEC regulations.

Stakeholder Impact

  • Shareholders: The disclosure provides transparency regarding insider stock movements, which can influence investor perception, though a 10b5-1 plan sale is generally less impactful than an ad-hoc sale.

Key Dates

DateDescription
02/28/2024Date Rule 10b5-1 plan was adopted by Karen Rapp.
05/30/2025Date of the reported transaction (sale of common stock).
06/02/2025Date the Form 4 filing was signed.

Keywords

Plexus Corp, PLXS, Form 4, insider trading, stock sale, director, Karen Rapp, 10b5-1 plan, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.